Eli Lilly and Company (LLY)
Is Eli Lilly Stock A Buy Or A Sell After FDA Delays Its Alzheimer's Drug Decision?
The FDA will now hold an advisory committee meeting to discuss Eli Lilly's Alzheimer's drug, donanemab. Is Eli Lilly stock a buy or a sell?
3 Biotech Stocks to Buy on the Dip: August 2024
With the current market volatility, knowing which biotech stocks to buy on the dip can lead to lucrative returns as the industry is likely to recover faster than the market average. After all, many of the most prominent biomedical developers see their stock price rise or fall based on their drug success.
Lilly demands doctors stop selling copycat weight-loss drugs, Bloomberg reports
Eli Lilly has sent cease-and-desist letters to US healthcare providers in recent days demanding they stop promoting copycat weight-loss drugs as the supply of the company's drug Zepbound improves, Bloomberg News reported on Wednesday.
Is Eli Lilly (LLY) a Buy Post Stellar Q2 Earnings & Raised View?
Eli Lilly (LLY) is a great stock to have in one's portfolio currently based on its strong overall financial performance and robust drug pipeline.
Up 10% in 1 Day, Is It Too Late to Buy Eli Lilly Stock?
The market reacted very positively to Eli Lilly's Q2 earnings report. This isn't the first time the stock has seen a significant run-up in a short period.
Lilly (LLY) Upgraded to Buy: Here's Why
Lilly (LLY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
3 Big Drug Stocks to Watch on Raised 2024 Earnings & Sales View
Here we discuss three drugmakers, Eli Lilly and Company (LLY), Pfizer (PFE) and AbbVie (ABBV), following their increase in sales and earnings guidance for 2024.
Wall Street Analysts See Lilly (LLY) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
3 Stocks on the Rise After Stellar Q2 Earnings Results
A large majority of the companies have already reported second-quarter results. While we can call it a mixed earnings season, there are a few companies that beat expectations and reported record revenue and profits.
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
What's Next For Eli Lilly Stock After A Solid Q2?
Eli Lilly stock (NYSE: LLY) recently reported its Q2 results, with revenues and earnings exceeding the street expectations. The pharmaceutical giant reported sales of $11.3 billion and adjusted earnings of $3.92 per share, compared to the consensus estimates of $9.9 billion and $2.60, respectively.
This 1 Piece of Good News for Eli Lilly Is Bad News for Hims & Hers Health Stock
Eli Lilly claims that it's finally producing enough of its weight loss drugs. Companies producing substitutes for those drugs may have trouble growing soon.
